CRCA vs. SOFR

Last updated Jun 4, 2026

CRCA (ProShares Ultra CRCL) and SOFR (Amplify Samsung SOFR ETF) are both exchange-traded funds - CRCA is a Leveraged Equities fund actively managed by ProShares, while SOFR is a Multisector Bonds fund tracking the Secured Overnight Financing Rate. CRCA is actively managed, while SOFR is passively managed. At a correlation of -0.08, they often move in opposite directions. CRCA charges 0.95%/yr vs 0.20%/yr for SOFR.

Performance

CRCA vs. SOFR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ProShares Ultra CRCL (CRCA) and Amplify Samsung SOFR ETF (SOFR). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CRCA achieves a -25.37% return, which is significantly lower than SOFR's 1.45% return.

CRCA

• 1D: -20.86%
• 1M: -48.25%
• YTD: -25.37%
• 6M: -39.99%
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

SOFR

• 1D: 0.00%
• 1M: 0.25%
• YTD: 1.45%
• 6M: 1.76%
• 1Y: 3.90%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

CRCA vs. SOFR - Yearly Performance Comparison

	2026 (YTD)	2025
CRCA ProShares Ultra CRCL	-25.37%	-81.81%
SOFR Amplify Samsung SOFR ETF	1.45%	1.64%

Correlation

The correlation between CRCA and SOFR is -0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (All Time) Calculated using the full available price history since Aug 8, 2025	-0.08

Return for Risk

CRCA vs. SOFR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SOFR

SOFR Risk / Return Rank: 97
SOFR Sharpe Ratio Rank: 97
SOFR Sortino Ratio Rank: 98
SOFR Omega Ratio Rank: 99
SOFR Calmar Ratio Rank: 96
SOFR Martin Ratio Rank: 96

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CRCA vs. SOFR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra CRCL (CRCA) and Amplify Samsung SOFR ETF (SOFR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	CRCA	SOFR	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	4.66	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.47	4.96	-5.42

Drawdowns

CRCA vs. SOFR - Drawdown Comparison

The maximum CRCA drawdown since its inception was -94.02%, which is greater than SOFR's maximum drawdown of -0.41%. Use the drawdown chart below to compare losses from any high point for CRCA and SOFR.

Drawdown Indicators

	CRCA	SOFR	Difference
Max Drawdown Largest peak-to-trough decline	-94.02%	-0.41%	-93.61%
Max Drawdown (1Y) Largest decline over 1 year	—	-0.41%	—
Current Drawdown Current decline from peak	-87.98%	-0.14%	-87.84%
Average Drawdown Average peak-to-trough decline	-69.26%	-0.03%	-69.23%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	0.10%	—

Volatility

Volatility by Period

	CRCA	SOFR	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	0.24%	—
Volatility (6M) Calculated over the trailing 6-month period	—	0.55%	—
Volatility (1Y) Calculated over the trailing 1-year period	196.79%	0.84%	+195.95%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	196.79%	0.84%	+195.95%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	196.79%	0.84%	+195.95%

CRCA vs. SOFR - Expense Ratio Comparison

CRCA has a 0.95% expense ratio, which is higher than SOFR's 0.20% expense ratio.

Dividends

CRCA vs. SOFR - Dividend Comparison

CRCA's dividend yield for the trailing twelve months is around 2.32%, less than SOFR's 3.95% yield.

Position	TTM	2025	2024
CRCA ProShares Ultra CRCL	2.32%	1.06%	0.00%
SOFR Amplify Samsung SOFR ETF	3.95%	4.22%	1.60%

Frequently Asked Questions

Can I hold both CRCA and SOFR in my portfolio?

CRCA and SOFR have a correlation of -0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, CRCA or SOFR?

On fees, SOFR is cheaper at 0.20% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, CRCA or SOFR?

SOFR is cheaper with a 0.20% expense ratio, compared with 0.95% for CRCA.

Which ETF pays a higher dividend yield, CRCA or SOFR?

SOFR has the higher dividend yield at 3.95%, compared with 2.32% for CRCA.

What is the main difference between CRCA and SOFR?

CRCA is categorized as Leveraged Equities, while SOFR is Multisector Bonds. They also come from different issuers: ProShares and Amplify. Their fees differ too: 0.95% for CRCA and 0.20% for SOFR.